JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
42 hedge funds and large institutions have $18.1M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
Holders
42
Holding in Top 10
–
Calls
$497K
Puts
$300K
Top Buyers
| 1 | +$580K | |
| 2 | +$538K | |
| 3 | +$468K | |
| 4 |
DMK
David M. Knott
|
+$415K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$286K |
Top Sellers
| 1 | -$389K | |
| 2 | -$287K | |
| 3 | -$232K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$108K |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$101K |